Fifty 1 Labs, Inc.
FITY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$236.26K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $236,255.00 |
|---|---|
| Enterprise Value | $399,744.00 |
| Earnings per Share | $0 |
| Beta | 2.66 |
| Outstanding Shares | 1,181,272,675 |
Return
| Return on Equity | 30.91% |
|---|---|
| Return on Assets | -3859.77% |
| Return on Invested Capital | 26.86% |
Valuation & Multiples
| P/E Ratio | -0.48 |
|---|---|
| PEG | -0.02 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 8505.19 |
| Enterprise Value to EBIT | -2.37 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.42 |
| Debt to Equity | -0.21 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Fifty 1 Labs, Inc.
2 employees
CEO: Joel Gagnier
Fifty 1 Labs, Inc. is a Nevada-based holding company that has shifted its focus to biotechnology and telehealth, centering on peptide science for musculoskeletal health, recovery, and performance. The company utilizes AI-driven research ...